Estonia

Estonia

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
0 (0 - 2) 2013 Survey/reported Parke, 2017
1.12 (0.18 - 7.92) 2015 Modelled WHO
0.5 (0.50 - 0.60) 2016 Modelled Razavi-Shearer et al, 2018
0.53 (0.45 - 0.61) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.58 (0.50 - 0.67) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.50 - 0.69) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.51 - 0.69) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.6 (0.51 - 0.70) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.61 (0.53 - 0.69) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.62 (0.54 - 0.70) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.63 (0.55 - 0.72) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.56 - 0.74) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.66 (0.57 - 0.75) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.58 - 0.76) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.69 (0.59 - 0.78) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.7 (0.60 - 0.80) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.72 (0.61 - 0.82) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.61 - 0.84) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.73 (0.62 - 0.84) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.74 (0.63 - 0.85) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.64 - 0.86) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.75 (0.64 - 0.87) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.76 (0.65 - 0.88) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.77 (0.66 - 0.89) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.78 (0.67 - 0.90) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.68 - 0.92) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.69 - 0.93) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.69 - 0.94) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.68 - 0.94) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.68 - 0.93) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.81 (0.67 - 0.93) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.66 - 0.94) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.8 (0.65 - 0.94) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.57 (0.48 - 0.66) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.36 (0.06 - 2.81) 2015 Modelled WHO
0.03 (0.02 - 0.04) 2019 Modelled IHME, GBD 2019 (accessed 2020)
0.05 (0.03 - 0.06) 2019 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2018 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2017 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2016 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2015 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2014 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2013 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2012 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2011 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2010 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
0.04 (0.03 - 0.06) 2008 Modelled IHME, GBD 2019 (accessed 2022)
0.05 (0.03 - 0.06) 2007 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.07) 2006 Modelled IHME, GBD 2019 (accessed 2022)
0.06 (0.04 - 0.09) 2005 Modelled IHME, GBD 2019 (accessed 2022)
0.11 (0.07 - 0.14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
0.19 (0.14 - 0.26) 2003 Modelled IHME, GBD 2019 (accessed 2022)
0.3 (0.21 - 0.40) 2002 Modelled IHME, GBD 2019 (accessed 2022)
0.4 (0.29 - 0.54) 2001 Modelled IHME, GBD 2019 (accessed 2022)
0.48 (0.34 - 0.64) 2000 Modelled IHME, GBD 2019 (accessed 2022)
0.54 (0.38 - 0.72) 1999 Modelled IHME, GBD 2019 (accessed 2022)
0.59 (0.42 - 0.78) 1998 Modelled IHME, GBD 2019 (accessed 2022)
0.64 (0.45 - 0.85) 1997 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.47 - 0.89) 1996 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.47 - 0.92) 1995 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.48 - 0.91) 1994 Modelled IHME, GBD 2019 (accessed 2022)
0.68 (0.48 - 0.90) 1993 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.47 - 0.90) 1992 Modelled IHME, GBD 2019 (accessed 2022)
0.67 (0.46 - 0.90) 1991 Modelled IHME, GBD 2019 (accessed 2022)
0.65 (0.44 - 0.91) 1990 Modelled IHME, GBD 2019 (accessed 2022)
0.29 (0.16 - 0.49) 2020 Modelled WHO
Showing out of
Show more
People who inject drugs (PWID)
Download
Value (%) Year Type Source
4 2013 Survey/reported EMCDDA
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.03 (0 - 5.60) 2015 Survey/reported K. R. Tervise Arengu Instituut, 2015.
1.03 2015 Survey/reported ECDC
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
7,000 (6,000 - 7,000) 2016 Modelled Razavi-Shearer et al, 2018
6,929 (5,891 - 8,046) 2019 Modelled IHME, GBD 2019 (accessed 2020)
7,132 (6,065 - 8,245) 2019 Modelled IHME, GBD 2019 (accessed 2022)
7,304 (6,227 - 8,375) 2018 Modelled IHME, GBD 2019 (accessed 2022)
7,392 (6,238 - 8,634) 2017 Modelled IHME, GBD 2019 (accessed 2022)
7,464 (6,377 - 8,630) 2016 Modelled IHME, GBD 2019 (accessed 2022)
7,535 (6,429 - 8,718) 2015 Modelled IHME, GBD 2019 (accessed 2022)
7,622 (6,581 - 8,717) 2014 Modelled IHME, GBD 2019 (accessed 2022)
7,790 (6,763 - 8,859) 2013 Modelled IHME, GBD 2019 (accessed 2022)
8,002 (6,932 - 9,095) 2012 Modelled IHME, GBD 2019 (accessed 2022)
8,218 (7,099 - 9,340) 2011 Modelled IHME, GBD 2019 (accessed 2022)
8,395 (7,211 - 9,566) 2010 Modelled IHME, GBD 2019 (accessed 2022)
8,578 (7,398 - 9,747) 2009 Modelled IHME, GBD 2019 (accessed 2022)
8,810 (7,561 - 9,958) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9,060 (7,701 - 10,331) 2007 Modelled IHME, GBD 2019 (accessed 2022)
9,292 (7,856 - 10,598) 2006 Modelled IHME, GBD 2019 (accessed 2022)
9,459 (7,944 - 10,889) 2005 Modelled IHME, GBD 2019 (accessed 2022)
9,592 (8,124 - 11,026) 2004 Modelled IHME, GBD 2019 (accessed 2022)
9,739 (8,304 - 11,211) 2003 Modelled IHME, GBD 2019 (accessed 2022)
9,886 (8,444 - 11,434) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10,016 (8,567 - 11,621) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10,108 (8,644 - 11,781) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10,232 (8,750 - 11,789) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10,458 (8,968 - 12,060) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10,741 (9,234 - 12,389) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11,026 (9,424 - 12,716) 1996 Modelled IHME, GBD 2019 (accessed 2022)
11,256 (9,529 - 12,995) 1995 Modelled IHME, GBD 2019 (accessed 2022)
11,459 (9,677 - 13,198) 1994 Modelled IHME, GBD 2019 (accessed 2022)
11,672 (9,817 - 13,432) 1993 Modelled IHME, GBD 2019 (accessed 2022)
11,841 (9,829 - 13,663) 1992 Modelled IHME, GBD 2019 (accessed 2022)
11,906 (9,805 - 13,987) 1991 Modelled IHME, GBD 2019 (accessed 2022)
11,852 (9,618 - 14,011) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
3.75 (2.63 - 5.28) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.78 (2.17 - 3.50) 1990 Modelled IHME, GBD 2019 (accessed 2022)
3 (2.33 - 3.78) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.08 (2.40 - 3.86) 1992 Modelled IHME, GBD 2019 (accessed 2022)
4.52 (3.45 - 5.76) 1994 Modelled IHME, GBD 2019 (accessed 2022)
4.71 (3.65 - 5.99) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.72 (2.86 - 4.72) 1993 Modelled IHME, GBD 2019 (accessed 2022)
4.38 (3.40 - 5.52) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.86 (3.78 - 6.18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
5.55 (4.33 - 7) 1998 Modelled IHME, GBD 2019 (accessed 2022)
5.61 (4.37 - 7.05) 1999 Modelled IHME, GBD 2019 (accessed 2022)
6.02 (4.61 - 7.64) 2000 Modelled IHME, GBD 2019 (accessed 2022)
6.7 (5.15 - 8.49) 2002 Modelled IHME, GBD 2019 (accessed 2022)
6.63 (5.08 - 8.41) 2001 Modelled IHME, GBD 2019 (accessed 2022)
6.66 (5.11 - 8.52) 2003 Modelled IHME, GBD 2019 (accessed 2022)
6.84 (5.18 - 8.74) 2005 Modelled IHME, GBD 2019 (accessed 2022)
6.79 (5.17 - 8.68) 2004 Modelled IHME, GBD 2019 (accessed 2022)
6.94 (5.22 - 8.92) 2006 Modelled IHME, GBD 2019 (accessed 2022)
7.1 (5.35 - 9.17) 2007 Modelled IHME, GBD 2019 (accessed 2022)
6.41 (4.83 - 8.34) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.79 (4.40 - 7.50) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.14 (3.92 - 6.67) 2010 Modelled IHME, GBD 2019 (accessed 2022)
4.99 (3.80 - 6.50) 2011 Modelled IHME, GBD 2019 (accessed 2022)
4.64 (3.55 - 6.08) 2012 Modelled IHME, GBD 2019 (accessed 2022)
4.14 (3.17 - 5.42) 2013 Modelled IHME, GBD 2019 (accessed 2022)
3.99 (3.02 - 5.26) 2014 Modelled IHME, GBD 2019 (accessed 2022)
3.86 (2.91 - 5.09) 2015 Modelled IHME, GBD 2019 (accessed 2022)
3.99 (3.02 - 5.29) 2016 Modelled IHME, GBD 2019 (accessed 2022)
3.88 (2.89 - 5.28) 2017 Modelled IHME, GBD 2019 (accessed 2022)
3.81 (2.72 - 5.28) 2018 Modelled IHME, GBD 2019 (accessed 2022)
3.75 (2.63 - 5.28) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
53 2016 Modelled WHO
44 (34 - 55) 1990 Modelled IHME, GBD 2019 (accessed 2022)
47 (36 - 59) 1991 Modelled IHME, GBD 2019 (accessed 2022)
48 (37 - 60) 1992 Modelled IHME, GBD 2019 (accessed 2022)
67 (51 - 85) 1994 Modelled IHME, GBD 2019 (accessed 2022)
56 (43 - 71) 1993 Modelled IHME, GBD 2019 (accessed 2022)
68 (53 - 87) 1995 Modelled IHME, GBD 2019 (accessed 2022)
63 (49 - 79) 1996 Modelled IHME, GBD 2019 (accessed 2022)
69 (53 - 87) 1997 Modelled IHME, GBD 2019 (accessed 2022)
78 (61 - 99) 1999 Modelled IHME, GBD 2019 (accessed 2022)
78 (61 - 98) 1998 Modelled IHME, GBD 2019 (accessed 2022)
84 (64 - 106) 2000 Modelled IHME, GBD 2019 (accessed 2022)
92 (71 - 117) 2001 Modelled IHME, GBD 2019 (accessed 2022)
93 (71 - 117) 2002 Modelled IHME, GBD 2019 (accessed 2022)
92 (70 - 117) 2003 Modelled IHME, GBD 2019 (accessed 2022)
93 (71 - 119) 2004 Modelled IHME, GBD 2019 (accessed 2022)
95 (72 - 123) 2007 Modelled IHME, GBD 2019 (accessed 2022)
93 (70 - 119) 2005 Modelled IHME, GBD 2019 (accessed 2022)
94 (71 - 121) 2006 Modelled IHME, GBD 2019 (accessed 2022)
86 (65 - 112) 2008 Modelled IHME, GBD 2019 (accessed 2022)
77 (59 - 100) 2009 Modelled IHME, GBD 2019 (accessed 2022)
69 (52 - 89) 2010 Modelled IHME, GBD 2019 (accessed 2022)
66 (51 - 86) 2011 Modelled IHME, GBD 2019 (accessed 2022)
61 (47 - 80) 2012 Modelled IHME, GBD 2019 (accessed 2022)
55 (42 - 72) 2013 Modelled IHME, GBD 2019 (accessed 2022)
51 (38 - 67) 2015 Modelled IHME, GBD 2019 (accessed 2022)
52 (40 - 70) 2016 Modelled IHME, GBD 2019 (accessed 2022)
53 (40 - 69) 2014 Modelled IHME, GBD 2019 (accessed 2022)
51 (38 - 69) 2017 Modelled IHME, GBD 2019 (accessed 2022)
50 (36 - 69) 2018 Modelled IHME, GBD 2019 (accessed 2022)
49 (35 - 69) 2019 Modelled IHME, GBD 2019 (accessed 2022)
49 (35 - 69) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
5 (4 - 7) 1990 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1991 Modelled IHME, GBD 2019 (accessed 2022)
6 (4 - 8) 1992 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 10) 1994 Modelled IHME, GBD 2019 (accessed 2022)
6 (5 - 9) 1993 Modelled IHME, GBD 2019 (accessed 2022)
8 (6 - 11) 1995 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1996 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 1997 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 1998 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 1999 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2000 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2002 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2001 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2003 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2004 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2006 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2005 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2007 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 2008 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2009 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2011 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2010 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 13) 2012 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2013 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2016 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2015 Modelled IHME, GBD 2019 (accessed 2022)
9 (7 - 13) 2014 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 15) 2017 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2018 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 14) 2019 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 23) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
91 2019 Survey/reported WHO/UNICEF
90 2020 Survey/reported WHO/UNICEF
84 2021 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
232 2017 Survey/reported EMCDDA, 2019
249 (135 - 339) 2016 Survey/reported Estonia National Institute for Health Development, 2016.
232 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
1.4 (0.90 - 1.60) 2015 Modelled Blach et al, 2017
2.16 (1.76 - 2.64) 2019 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.78 - 2.63) 2018 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.77 - 2.62) 2017 Modelled IHME, GBD 2019 (accessed 2022)
2.13 (1.75 - 2.60) 2016 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.72 - 2.59) 2015 Modelled IHME, GBD 2019 (accessed 2022)
2.12 (1.73 - 2.60) 2014 Modelled IHME, GBD 2019 (accessed 2022)
2.13 (1.74 - 2.60) 2013 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.75 - 2.60) 2012 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.76 - 2.62) 2011 Modelled IHME, GBD 2019 (accessed 2022)
2.17 (1.75 - 2.63) 2010 Modelled IHME, GBD 2019 (accessed 2022)
2.17 (1.75 - 2.62) 2009 Modelled IHME, GBD 2019 (accessed 2022)
2.16 (1.75 - 2.63) 2008 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.76 - 2.61) 2007 Modelled IHME, GBD 2019 (accessed 2022)
2.15 (1.74 - 2.62) 2006 Modelled IHME, GBD 2019 (accessed 2022)
2.14 (1.73 - 2.62) 2005 Modelled IHME, GBD 2019 (accessed 2022)
2.13 (1.73 - 2.59) 2004 Modelled IHME, GBD 2019 (accessed 2022)
2.11 (1.72 - 2.59) 2003 Modelled IHME, GBD 2019 (accessed 2022)
2.1 (1.71 - 2.56) 2002 Modelled IHME, GBD 2019 (accessed 2022)
2.08 (1.69 - 2.56) 2001 Modelled IHME, GBD 2019 (accessed 2022)
2.07 (1.67 - 2.55) 2000 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.66 - 2.52) 1999 Modelled IHME, GBD 2019 (accessed 2022)
2.03 (1.65 - 2.49) 1998 Modelled IHME, GBD 2019 (accessed 2022)
2.01 (1.64 - 2.47) 1997 Modelled IHME, GBD 2019 (accessed 2022)
1.99 (1.61 - 2.45) 1996 Modelled IHME, GBD 2019 (accessed 2022)
1.97 (1.59 - 2.44) 1995 Modelled IHME, GBD 2019 (accessed 2022)
1.96 (1.59 - 2.41) 1994 Modelled IHME, GBD 2019 (accessed 2022)
1.95 (1.57 - 2.39) 1993 Modelled IHME, GBD 2019 (accessed 2022)
1.93 (1.56 - 2.38) 1992 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.55 - 2.37) 1991 Modelled IHME, GBD 2019 (accessed 2022)
1.92 (1.53 - 2.37) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.05 (1.67 - 2.51) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value (%) Year Type Source
1.49 (0.96 - 1.64) 2019 Modelled Dugan et al., 2021
Technical notes

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
0 (0 - 2) 2013 Survey/reported Parker, 2018
People who inject drugs (PWID)
Download
Value (%) Year Type Source
79.2 (67.40 - 91) 2014 Modelled Degenhardt L et al, 2017
89.3 2017 Survey/reported EMCDDA
Showing out of
Show more
Men who have sex with men (MSM)
Download
Value (%) Year Type Source
1.8 (0.20 - 6.20) 2015 Survey/reported K. R. Tervise Arengu Instituut, 201
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
18,000 (12,000 - 20,000) 2015 Modelled Blach et al, 2017
28,592 (22,889 - 35,396) 1990 Modelled IHME, GBD 2019 (accessed 2022)
28,553 (23,113 - 35,133) 1991 Modelled IHME, GBD 2019 (accessed 2022)
28,376 (22,924 - 34,846) 1992 Modelled IHME, GBD 2019 (accessed 2022)
28,055 (22,774 - 34,481) 1993 Modelled IHME, GBD 2019 (accessed 2022)
27,666 (22,548 - 34,005) 1994 Modelled IHME, GBD 2019 (accessed 2022)
27,318 (22,143 - 33,727) 1995 Modelled IHME, GBD 2019 (accessed 2022)
27,121 (22,040 - 33,397) 1996 Modelled IHME, GBD 2019 (accessed 2022)
27,100 (22,070 - 33,361) 1997 Modelled IHME, GBD 2019 (accessed 2022)
27,188 (22,185 - 33,358) 1998 Modelled IHME, GBD 2019 (accessed 2022)
27,355 (22,219 - 33,506) 1999 Modelled IHME, GBD 2019 (accessed 2022)
27,548 (22,317 - 33,942) 2000 Modelled IHME, GBD 2019 (accessed 2022)
27,678 (22,534 - 33,924) 2001 Modelled IHME, GBD 2019 (accessed 2022)
27,770 (22,587 - 33,868) 2002 Modelled IHME, GBD 2019 (accessed 2022)
27,825 (22,691 - 33,979) 2003 Modelled IHME, GBD 2019 (accessed 2022)
27,841 (22,658 - 33,902) 2004 Modelled IHME, GBD 2019 (accessed 2022)
27,816 (22,469 - 33,952) 2005 Modelled IHME, GBD 2019 (accessed 2022)
27,762 (22,559 - 33,755) 2006 Modelled IHME, GBD 2019 (accessed 2022)
27,710 (22,533 - 33,597) 2007 Modelled IHME, GBD 2019 (accessed 2022)
27,669 (22,450 - 33,500) 2008 Modelled IHME, GBD 2019 (accessed 2022)
27,640 (22,331 - 33,491) 2009 Modelled IHME, GBD 2019 (accessed 2022)
27,609 (22,311 - 33,457) 2010 Modelled IHME, GBD 2019 (accessed 2022)
27,467 (22,348 - 33,199) 2011 Modelled IHME, GBD 2019 (accessed 2022)
27,192 (22,196 - 32,891) 2012 Modelled IHME, GBD 2019 (accessed 2022)
26,888 (21,903 - 32,715) 2013 Modelled IHME, GBD 2019 (accessed 2022)
26,651 (21,760 - 32,614) 2014 Modelled IHME, GBD 2019 (accessed 2022)
26,582 (21,603 - 32,578) 2015 Modelled IHME, GBD 2019 (accessed 2022)
26,771 (22,029 - 32,678) 2016 Modelled IHME, GBD 2019 (accessed 2022)
26,975 (22,236 - 32,950) 2017 Modelled IHME, GBD 2019 (accessed 2022)
27,021 (22,319 - 33,058) 2018 Modelled IHME, GBD 2019 (accessed 2022)
26,878 (21,923 - 32,931) 2019 Modelled IHME, GBD 2019 (accessed 2020)
27,000 (22,039 - 33,059) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Women of childbearing age (15–49 years)
Download
Value Year Type Source
4,200 (2,700 - 4,700) 2019 Modelled Dugan et al., 2021

HCV-related death rate

National
Download
Value (Deaths per 100,000) Year Type Source
5.68 (3.97 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2020)
2.29 (1.78 - 2.95) 1990 Modelled IHME, GBD 2019 (accessed 2022)
2.54 (1.97 - 3.23) 1992 Modelled IHME, GBD 2019 (accessed 2022)
2.46 (1.92 - 3.17) 1991 Modelled IHME, GBD 2019 (accessed 2022)
3.65 (2.79 - 4.74) 1994 Modelled IHME, GBD 2019 (accessed 2022)
3.02 (2.34 - 3.90) 1993 Modelled IHME, GBD 2019 (accessed 2022)
3.82 (2.98 - 4.96) 1995 Modelled IHME, GBD 2019 (accessed 2022)
3.63 (2.81 - 4.62) 1996 Modelled IHME, GBD 2019 (accessed 2022)
4.04 (3.16 - 5.18) 1997 Modelled IHME, GBD 2019 (accessed 2022)
4.58 (3.59 - 5.96) 1998 Modelled IHME, GBD 2019 (accessed 2022)
4.68 (3.65 - 6.03) 1999 Modelled IHME, GBD 2019 (accessed 2022)
5.01 (3.89 - 6.47) 2000 Modelled IHME, GBD 2019 (accessed 2022)
5.53 (4.30 - 7.22) 2002 Modelled IHME, GBD 2019 (accessed 2022)
5.47 (4.21 - 7.12) 2001 Modelled IHME, GBD 2019 (accessed 2022)
5.53 (4.28 - 7.18) 2003 Modelled IHME, GBD 2019 (accessed 2022)
5.62 (4.32 - 7.32) 2004 Modelled IHME, GBD 2019 (accessed 2022)
5.69 (4.41 - 7.38) 2005 Modelled IHME, GBD 2019 (accessed 2022)
5.81 (4.46 - 7.61) 2006 Modelled IHME, GBD 2019 (accessed 2022)
6.05 (4.62 - 8) 2007 Modelled IHME, GBD 2019 (accessed 2022)
5.72 (4.43 - 7.48) 2008 Modelled IHME, GBD 2019 (accessed 2022)
5.08 (3.90 - 6.54) 2010 Modelled IHME, GBD 2019 (accessed 2022)
5.41 (4.16 - 7.05) 2009 Modelled IHME, GBD 2019 (accessed 2022)
5.25 (4.06 - 6.81) 2011 Modelled IHME, GBD 2019 (accessed 2022)
5.35 (4.12 - 6.95) 2012 Modelled IHME, GBD 2019 (accessed 2022)
5.36 (4.13 - 6.93) 2013 Modelled IHME, GBD 2019 (accessed 2022)
5.64 (4.32 - 7.38) 2014 Modelled IHME, GBD 2019 (accessed 2022)
5.7 (4.40 - 7.41) 2015 Modelled IHME, GBD 2019 (accessed 2022)
5.95 (4.57 - 7.65) 2016 Modelled IHME, GBD 2019 (accessed 2022)
5.81 (4.40 - 7.64) 2017 Modelled IHME, GBD 2019 (accessed 2022)
5.73 (4.13 - 7.83) 2018 Modelled IHME, GBD 2019 (accessed 2022)
5.68 (3.97 - 8) 2019 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
107 2016 Modelled WHO
75 (52 - 105) 2019 Modelled IHME, GBD 2019 (accessed 2022)
75 (52 - 105) 2019 Modelled IHME, GBD 2019 (accessed 2020)
75 (54 - 103) 2018 Modelled IHME, GBD 2019 (accessed 2022)
76 (58 - 100) 2017 Modelled IHME, GBD 2019 (accessed 2022)
78 (60 - 101) 2016 Modelled IHME, GBD 2019 (accessed 2022)
75 (58 - 97) 2015 Modelled IHME, GBD 2019 (accessed 2022)
74 (57 - 97) 2014 Modelled IHME, GBD 2019 (accessed 2022)
71 (55 - 91) 2013 Modelled IHME, GBD 2019 (accessed 2022)
71 (55 - 92) 2012 Modelled IHME, GBD 2019 (accessed 2022)
70 (54 - 90) 2011 Modelled IHME, GBD 2019 (accessed 2022)
68 (52 - 87) 2010 Modelled IHME, GBD 2019 (accessed 2022)
72 (56 - 94) 2009 Modelled IHME, GBD 2019 (accessed 2022)
77 (59 - 100) 2008 Modelled IHME, GBD 2019 (accessed 2022)
81 (62 - 108) 2007 Modelled IHME, GBD 2019 (accessed 2022)
78 (60 - 103) 2006 Modelled IHME, GBD 2019 (accessed 2022)
77 (60 - 100) 2005 Modelled IHME, GBD 2019 (accessed 2022)
77 (59 - 100) 2004 Modelled IHME, GBD 2019 (accessed 2022)
76 (59 - 99) 2003 Modelled IHME, GBD 2019 (accessed 2022)
77 (59 - 100) 2002 Modelled IHME, GBD 2019 (accessed 2022)
76 (59 - 99) 2001 Modelled IHME, GBD 2019 (accessed 2022)
70 (54 - 90) 2000 Modelled IHME, GBD 2019 (accessed 2022)
65 (51 - 84) 1999 Modelled IHME, GBD 2019 (accessed 2022)
64 (50 - 84) 1998 Modelled IHME, GBD 2019 (accessed 2022)
57 (45 - 73) 1997 Modelled IHME, GBD 2019 (accessed 2022)
52 (40 - 66) 1996 Modelled IHME, GBD 2019 (accessed 2022)
55 (43 - 72) 1995 Modelled IHME, GBD 2019 (accessed 2022)
54 (41 - 70) 1994 Modelled IHME, GBD 2019 (accessed 2022)
46 (35 - 59) 1993 Modelled IHME, GBD 2019 (accessed 2022)
39 (30 - 50) 1992 Modelled IHME, GBD 2019 (accessed 2022)
38 (30 - 49) 1991 Modelled IHME, GBD 2019 (accessed 2022)
36 (28 - 46) 1990 Modelled IHME, GBD 2019 (accessed 2022)
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
6 (5 - 8) 1990 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1991 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1992 Modelled IHME, GBD 2019 (accessed 2022)
8 (5 - 10) 1994 Modelled IHME, GBD 2019 (accessed 2022)
9 (6 - 12) 1995 Modelled IHME, GBD 2019 (accessed 2022)
7 (5 - 9) 1993 Modelled IHME, GBD 2019 (accessed 2022)
10 (7 - 13) 1996 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1997 Modelled IHME, GBD 2019 (accessed 2022)
11 (8 - 14) 1998 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 1999 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2001 Modelled IHME, GBD 2019 (accessed 2022)
12 (9 - 16) 2000 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2002 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2003 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2004 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2005 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2006 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 2008 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 17) 2007 Modelled IHME, GBD 2019 (accessed 2022)
13 (9 - 18) 2009 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2010 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2011 Modelled IHME, GBD 2019 (accessed 2022)
14 (10 - 18) 2012 Modelled IHME, GBD 2019 (accessed 2022)
15 (10 - 20) 2013 Modelled IHME, GBD 2019 (accessed 2022)
16 (11 - 21) 2015 Modelled IHME, GBD 2019 (accessed 2022)
15 (11 - 20) 2014 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 23) 2016 Modelled IHME, GBD 2019 (accessed 2022)
17 (12 - 22) 2017 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 22) 2018 Modelled IHME, GBD 2019 (accessed 2022)
16 (12 - 22) 2019 Modelled IHME, GBD 2019 (accessed 2022)
28 (20 - 36) 2019 Modelled IHME, GBD 2019 (accessed 2020)
Showing out of
Show more
Technical notes

Number of needles/syringes per PWID per year

People who inject drugs (PWID)
Download
Value Year Type Source
232 2017 Survey/reported EMCDDA, 2019
249 (135 - 339) 2016 Survey/reported Estonia National Institute for Health Development, 2016.
232 2017 Survey/reported ECDC
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
2003
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP
At least one needle-syringe exchange program (NSP) operational
Yes
Source: Harm Reduction International
At least one opioid substitution therapy (OST) program operational
Yes
Source: Harm Reduction International
NSP in at least one prison
No
Source: Harm Reduction International
OST in at least one prison
Yes
Source: Harm Reduction International

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
0.57 (%)
2019
(0.48 - 0.66(%))
IHME, GBD 2019 (accessed 2022)
HCV (RNA/cAg+)
2.05 (%)
2019
(1.67 - 2.51(%))
IHME, GBD 2019 (accessed 2020)

Survey/surveillance

HBV (HBsAg+)
0 (%)
2013
(0 - 2(%))
Parke, 2017
HCV (anti-HCV)
0 (%)
2013
(0 - 2(%))
Parker, 2018

Hepatitis related deaths (national)

Modelled

HBV
49
2019
(35 - 69)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HBV chart

Modelled

HCV
75
2019
(52 - 105)
IHME, GBD 2019 (accessed 2022)

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.29 (%)
2020, latest modelled
(0.16 - 0.49(%))
WHO

Prevalence PWID

HCV
89.30 (%)
2017, survey/surveillance
EMCDDA

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

HCV
232
2017
EMCDDA, 2019
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources